Clinical Trial Update: PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating PV-10 in combination with pembrolizumab for metastatic melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• PV-10 (Rose Bengal disodium)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Provectus Biopharmaceuticals, Inc. | Conditions: Melanoma | Phase 1, Phase 2 | Status: UNKNOWN